HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-AUG-12 4GHR TITLE TGT D102N MUTANT IN COMPLEX WITH LIN-BENZOHYPOXANTHINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: QUEUINE TRNA-RIBOSYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GUANINE INSERTION ENZYME, TRNA-GUANINE TRANSGLYCOSYLASE; COMPND 5 EC: 2.4.2.29; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZYMOMONAS MOBILIS SUBSP. MOBILIS; SOURCE 3 ORGANISM_TAXID: 264203; SOURCE 4 STRAIN: ATCC 31821 / ZM4 / CP4; SOURCE 5 GENE: TGT, ZMO0363; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET9D KEYWDS TIM BARREL, GLYCOSYLTRANSFERASE, QUEUOSINE, TRNA PROCESSING, KEYWDS 2 BIOSYNTHESIS, TRNA, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.IMMEKUS,G.KLEBE REVDAT 4 13-SEP-23 4GHR 1 REMARK SEQADV LINK REVDAT 3 17-JUL-19 4GHR 1 REMARK REVDAT 2 07-MAR-18 4GHR 1 REMARK REVDAT 1 04-SEP-13 4GHR 0 JRNL AUTH F.IMMEKUS,L.J.BARANDUN,F.DIEDERICH,G.KLEBE JRNL TITL PROTONATION STATE ANALYSIS OF THE TGT ACTIVE SITE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.177 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.177 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1237 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 25678 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.162 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 20542 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2633 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 23 REMARK 3 SOLVENT ATOMS : 217 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2874.0 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2541.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 3 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 11591 REMARK 3 NUMBER OF RESTRAINTS : 11130 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 ANGLE DISTANCES (A) : 0.020 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.021 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.027 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.032 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.011 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.059 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56 REMARK 4 REMARK 4 4GHR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074198. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26737 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 14.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.30700 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1P0D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM MES, 1MM DTT, 10% DMSO, 13% REMARK 280 PEG8000, PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.11200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.25900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.11200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.25900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: HOMODIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 VAL A 2 REMARK 465 GLU A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 THR A 9 REMARK 465 ASP A 10 REMARK 465 MET A 109 REMARK 465 SER A 110 REMARK 465 LEU A 111 REMARK 465 SER A 112 REMARK 465 SER A 113 REMARK 465 LEU A 114 REMARK 465 THR A 115 REMARK 465 LYS A 116 REMARK 465 PHE A 124 REMARK 465 LYS A 125 REMARK 465 SER A 126 REMARK 465 HIS A 127 REMARK 465 LEU A 128 REMARK 465 ASP A 129 REMARK 465 GLY A 130 REMARK 465 SER A 131 REMARK 465 ARG A 132 REMARK 465 HIS A 133 REMARK 465 ALA A 383 REMARK 465 ARG A 384 REMARK 465 ASN A 385 REMARK 465 SER A 386 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 11 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 31 CG CD OE1 OE2 REMARK 470 MET A 75 CG SD CE REMARK 470 LEU A 76 CG CD1 CD2 REMARK 470 ARG A 77 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 GLN A 107 CG CD OE1 NE2 REMARK 470 VAL A 108 CG1 CG2 REMARK 470 GLN A 117 CG CD OE1 NE2 REMARK 470 GLU A 120 CG CD OE1 OE2 REMARK 470 THR A 123 OG1 CG2 REMARK 470 MET A 134 CG SD CE REMARK 470 GLU A 157 CG CD OE1 OE2 REMARK 470 ARG A 167 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 190 CG CD CE NZ REMARK 470 GLU A 191 CG CD OE1 OE2 REMARK 470 GLU A 220 CG CD OE1 OE2 REMARK 470 ASP A 238 CG OD1 OD2 REMARK 470 ARG A 242 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 283 CG CD1 CD2 REMARK 470 ARG A 286 CG CD NE CZ NH1 NH2 REMARK 470 SER A 287 OG REMARK 470 ASN A 290 CG OD1 ND2 REMARK 470 ASN A 301 CG OD1 ND2 REMARK 470 ARG A 306 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 319 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 324 CG CD OE1 NE2 REMARK 470 LYS A 325 CG CD CE NZ REMARK 470 SER A 371 OG REMARK 470 GLN A 375 CG CD OE1 NE2 REMARK 470 ARG A 378 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 380 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 21 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A 34 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 336 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 48 57.06 70.50 REMARK 500 SER A 205 -138.47 53.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 318 SG REMARK 620 2 CYS A 320 SG 105.5 REMARK 620 3 CYS A 323 SG 112.4 117.4 REMARK 620 4 HIS A 349 ND1 104.1 114.4 102.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ITE A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3S1G RELATED DB: PDB REMARK 900 RELATED ID: 4GG9 RELATED DB: PDB REMARK 900 RELATED ID: 4GH1 RELATED DB: PDB REMARK 900 RELATED ID: 4GH3 RELATED DB: PDB REMARK 900 RELATED ID: 4GI4 RELATED DB: PDB DBREF 4GHR A 1 386 UNP P28720 TGT_ZYMMO 1 386 SEQADV 4GHR ASN A 102 UNP P28720 ASP 102 ENGINEERED MUTATION SEQADV 4GHR LYS A 312 UNP P28720 THR 312 ENGINEERED MUTATION SEQRES 1 A 386 MET VAL GLU ALA THR ALA GLN GLU THR ASP ARG PRO ARG SEQRES 2 A 386 PHE SER PHE SER ILE ALA ALA ARG GLU GLY LYS ALA ARG SEQRES 3 A 386 THR GLY THR ILE GLU MET LYS ARG GLY VAL ILE ARG THR SEQRES 4 A 386 PRO ALA PHE MET PRO VAL GLY THR ALA ALA THR VAL LYS SEQRES 5 A 386 ALA LEU LYS PRO GLU THR VAL ARG ALA THR GLY ALA ASP SEQRES 6 A 386 ILE ILE LEU GLY ASN THR TYR HIS LEU MET LEU ARG PRO SEQRES 7 A 386 GLY ALA GLU ARG ILE ALA LYS LEU GLY GLY LEU HIS SER SEQRES 8 A 386 PHE MET GLY TRP ASP ARG PRO ILE LEU THR ASN SER GLY SEQRES 9 A 386 GLY TYR GLN VAL MET SER LEU SER SER LEU THR LYS GLN SEQRES 10 A 386 SER GLU GLU GLY VAL THR PHE LYS SER HIS LEU ASP GLY SEQRES 11 A 386 SER ARG HIS MET LEU SER PRO GLU ARG SER ILE GLU ILE SEQRES 12 A 386 GLN HIS LEU LEU GLY SER ASP ILE VAL MET ALA PHE ASP SEQRES 13 A 386 GLU CYS THR PRO TYR PRO ALA THR PRO SER ARG ALA ALA SEQRES 14 A 386 SER SER MET GLU ARG SER MET ARG TRP ALA LYS ARG SER SEQRES 15 A 386 ARG ASP ALA PHE ASP SER ARG LYS GLU GLN ALA GLU ASN SEQRES 16 A 386 ALA ALA LEU PHE GLY ILE GLN GLN GLY SER VAL PHE GLU SEQRES 17 A 386 ASN LEU ARG GLN GLN SER ALA ASP ALA LEU ALA GLU ILE SEQRES 18 A 386 GLY PHE ASP GLY TYR ALA VAL GLY GLY LEU ALA VAL GLY SEQRES 19 A 386 GLU GLY GLN ASP GLU MET PHE ARG VAL LEU ASP PHE SER SEQRES 20 A 386 VAL PRO MET LEU PRO ASP ASP LYS PRO HIS TYR LEU MET SEQRES 21 A 386 GLY VAL GLY LYS PRO ASP ASP ILE VAL GLY ALA VAL GLU SEQRES 22 A 386 ARG GLY ILE ASP MET PHE ASP CYS VAL LEU PRO THR ARG SEQRES 23 A 386 SER GLY ARG ASN GLY GLN ALA PHE THR TRP ASP GLY PRO SEQRES 24 A 386 ILE ASN ILE ARG ASN ALA ARG PHE SER GLU ASP LEU LYS SEQRES 25 A 386 PRO LEU ASP SER GLU CYS HIS CYS ALA VAL CYS GLN LYS SEQRES 26 A 386 TRP SER ARG ALA TYR ILE HIS HIS LEU ILE ARG ALA GLY SEQRES 27 A 386 GLU ILE LEU GLY ALA MET LEU MET THR GLU HIS ASN ILE SEQRES 28 A 386 ALA PHE TYR GLN GLN LEU MET GLN LYS ILE ARG ASP SER SEQRES 29 A 386 ILE SER GLU GLY ARG PHE SER GLN PHE ALA GLN ASP PHE SEQRES 30 A 386 ARG ALA ARG TYR PHE ALA ARG ASN SER HET ZN A 401 1 HET ITE A 402 16 HET GOL A 403 6 HETNAM ZN ZINC ION HETNAM ITE 2-(METHYLAMINO)-1,7-DIHYDRO-8H-IMIDAZO[4,5- HETNAM 2 ITE G]QUINAZOLIN-8-ONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN ZN 2+ FORMUL 3 ITE C10 H9 N5 O FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *217(H2 O) HELIX 1 1 LYS A 55 GLY A 63 1 9 HELIX 2 2 ASN A 70 ARG A 77 1 8 HELIX 3 3 GLY A 79 LEU A 86 1 8 HELIX 4 4 GLY A 88 GLY A 94 1 7 HELIX 5 5 SER A 136 GLY A 148 1 13 HELIX 6 6 THR A 164 ARG A 189 1 26 HELIX 7 7 ARG A 189 ALA A 196 1 8 HELIX 8 8 PHE A 207 GLY A 222 1 16 HELIX 9 9 GLU A 235 VAL A 248 1 14 HELIX 10 10 PRO A 249 LEU A 251 5 3 HELIX 11 11 LYS A 264 ARG A 274 1 11 HELIX 12 12 VAL A 282 ASN A 290 1 9 HELIX 13 13 ASN A 304 SER A 308 5 5 HELIX 14 14 CYS A 320 TRP A 326 1 7 HELIX 15 15 SER A 327 ALA A 337 1 11 HELIX 16 16 GLU A 339 GLU A 367 1 29 HELIX 17 17 ARG A 369 PHE A 382 1 14 SHEET 1 A 3 SER A 15 GLU A 22 0 SHEET 2 A 3 ALA A 25 MET A 32 -1 O THR A 27 N ALA A 20 SHEET 3 A 3 GLY A 35 THR A 39 -1 O ILE A 37 N ILE A 30 SHEET 1 B 9 ALA A 41 GLY A 46 0 SHEET 2 B 9 ILE A 67 GLY A 69 1 O LEU A 68 N GLY A 46 SHEET 3 B 9 ILE A 99 THR A 101 1 O LEU A 100 N GLY A 69 SHEET 4 B 9 ILE A 151 MET A 153 1 O ILE A 151 N THR A 101 SHEET 5 B 9 ALA A 197 GLN A 202 1 O PHE A 199 N VAL A 152 SHEET 6 B 9 GLY A 225 VAL A 228 1 O ALA A 227 N GLY A 200 SHEET 7 B 9 HIS A 257 LEU A 259 1 O TYR A 258 N VAL A 228 SHEET 8 B 9 MET A 278 CYS A 281 1 O MET A 278 N LEU A 259 SHEET 9 B 9 ALA A 41 GLY A 46 1 N MET A 43 O PHE A 279 SHEET 1 C 2 GLN A 292 ALA A 293 0 SHEET 2 C 2 ILE A 300 ASN A 301 -1 O ILE A 300 N ALA A 293 LINK SG CYS A 318 ZN ZN A 401 1555 1555 2.24 LINK SG CYS A 320 ZN ZN A 401 1555 1555 2.34 LINK SG CYS A 323 ZN ZN A 401 1555 1555 2.30 LINK ND1 HIS A 349 ZN ZN A 401 1555 1555 2.28 CISPEP 1 THR A 39 PRO A 40 0 -8.75 CISPEP 2 ARG A 77 PRO A 78 0 0.78 CISPEP 3 TYR A 161 PRO A 162 0 -4.75 CISPEP 4 VAL A 262 GLY A 263 0 -4.00 SITE 1 AC1 4 CYS A 318 CYS A 320 CYS A 323 HIS A 349 SITE 1 AC2 14 TYR A 106 ASP A 156 CYS A 158 GLN A 203 SITE 2 AC2 14 GLY A 229 GLY A 230 LEU A 231 ALA A 232 SITE 3 AC2 14 VAL A 233 MET A 260 GLY A 261 HOH A 621 SITE 4 AC2 14 HOH A 641 HOH A 691 SITE 1 AC3 7 PRO A 56 GLU A 57 GLY A 94 TRP A 95 SITE 2 AC3 7 ASP A 96 ARG A 97 HOH A 639 CRYST1 90.224 64.518 70.592 90.00 95.58 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011084 0.000000 0.001083 0.00000 SCALE2 0.000000 0.015500 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014233 0.00000